Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP232284.RALRPNHHFMYA3niQo5zHK6CX0uZd_bSr_AdOcR87tEdnE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP232284.RALRPNHHFMYA3niQo5zHK6CX0uZd_bSr_AdOcR87tEdnE130_assertion type Assertion NP232284.RALRPNHHFMYA3niQo5zHK6CX0uZd_bSr_AdOcR87tEdnE130_head.
- NP232284.RALRPNHHFMYA3niQo5zHK6CX0uZd_bSr_AdOcR87tEdnE130_assertion description "[In contrast, SOCE agonists should attenuate mTOR inhibitors-mediated AKT reactivation and consequently potentiate their efficacy in the treatment of the patients with TSC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232284.RALRPNHHFMYA3niQo5zHK6CX0uZd_bSr_AdOcR87tEdnE130_provenance.
- NP232284.RALRPNHHFMYA3niQo5zHK6CX0uZd_bSr_AdOcR87tEdnE130_assertion evidence source_evidence_literature NP232284.RALRPNHHFMYA3niQo5zHK6CX0uZd_bSr_AdOcR87tEdnE130_provenance.
- NP232284.RALRPNHHFMYA3niQo5zHK6CX0uZd_bSr_AdOcR87tEdnE130_assertion SIO_000772 23108404 NP232284.RALRPNHHFMYA3niQo5zHK6CX0uZd_bSr_AdOcR87tEdnE130_provenance.
- NP232284.RALRPNHHFMYA3niQo5zHK6CX0uZd_bSr_AdOcR87tEdnE130_assertion wasDerivedFrom befree-20150227 NP232284.RALRPNHHFMYA3niQo5zHK6CX0uZd_bSr_AdOcR87tEdnE130_provenance.
- NP232284.RALRPNHHFMYA3niQo5zHK6CX0uZd_bSr_AdOcR87tEdnE130_assertion wasGeneratedBy ECO_0000203 NP232284.RALRPNHHFMYA3niQo5zHK6CX0uZd_bSr_AdOcR87tEdnE130_provenance.